Quantcast

WellDoc gets FDA OK on therapeutic

Columbia-based digital health technology company WellDoc announced that the U.S. Food and Drug Administration has granted it clearance for a non-prescription version of its BlueStar digital therapeutic. This will allow WellDoc more flexibility in offering the product through additional channels to adults living with Type 2 diabetes, the company said. “This FDA clearance is a significant milestone for ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*